University of South Florida

Digital Commons @ University of South Florida
Nursing Faculty Publications

College of Nursing

2020

Approach to High Volume Enrollment in Clinical Research:
Experiences from an All of Us Research Program Site
Titilayo O. Ilori
Boston University

Emma Viera
University of Arizona

Jillian Wilson
Kansas University Medical Center

Francisco Moreno
University of Arizona

Usha Menon
University of South Florida, umenon@usf.edu

See next page for additional authors
Follow this and additional works at: https://digitalcommons.usf.edu/nur_facpub

Scholar Commons Citation
Ilori, Titilayo O.; Viera, Emma; Wilson, Jillian; Moreno, Francisco; Menon, Usha; Ehiri, John; Peterson,
Rachele; Vemulapalli, Tejo; StimsonRiahi, Sara C.; Rosales, Cecilia; Calhoun, Elizabeth; Sokan, Amanda;
Karnes, Jason H.; Reiman, Eric; Ojo, Akinlolu; Theodorou, Andreas; and Ojo, Tammy, "Approach to High
Volume Enrollment in Clinical Research: Experiences from an All of Us Research Program Site" (2020).
Nursing Faculty Publications. 189.
https://digitalcommons.usf.edu/nur_facpub/189

This Article is brought to you for free and open access by the College of Nursing at Digital Commons @ University
of South Florida. It has been accepted for inclusion in Nursing Faculty Publications by an authorized administrator
of Digital Commons @ University of South Florida. For more information, please contact
scholarcommons@usf.edu.

Authors
Titilayo O. Ilori, Emma Viera, Jillian Wilson, Francisco Moreno, Usha Menon, John Ehiri, Rachele Peterson,
Tejo Vemulapalli, Sara C. StimsonRiahi, Cecilia Rosales, Elizabeth Calhoun, Amanda Sokan, Jason H.
Karnes, Eric Reiman, Akinlolu Ojo, Andreas Theodorou, and Tammy Ojo

This article is available at Digital Commons @ University of South Florida: https://digitalcommons.usf.edu/
nur_facpub/189

Citation: Clin Transl Sci (2020) 13, 685–692;

doi:10.1111/cts.12759

TUTORIAL

Approach to High Volume Enrollment in Clinical Research:
Experiences from an All of Us Research Program Site
Titilayo O. Ilori1,*, Emma Viera2, Jillian Wilson3, Francisco Moreno4, Usha Menon5, John Ehiri6, Rachele Peterson7, Tejo Vemulapalli8,
Sara C. StimsonRiahi9, Cecilia Rosales2, Elizabeth Calhoun10, Amanda Sokan2, Jason H. Karnes11, Eric Reiman12, Akinlolu Ojo13,
Andreas Theodorou14,15 and Tammy Ojo16

Clinical trials and cohort studies are required to meet target recruitment of study participants within stipulated timelines,
especially when the priority is to include populations traditionally unrepresented in biomedical research. By the third quarter
of 2019, the University of Arizona-Banner Health Provider Organization (UA-Banner HPO) has enrolled > 30,000 core participants into the All of Us Research Program (AoURP), the research cohort of the Precision Medicine Initiative. The majority
of enrolled participants meet the criteria for individuals under-represented in biomedical research. The enrollment goals
were calculated based on a target of 20,000 as set by the National Institutes of Health and our health provider organization
achieved enrollment numbers between 17% and 86% above the targeted daily enrollment. We evaluated enrollment methods
and challenges to enrollments encountered by the UA-Banner Health Provider Organization into the AoURP. Challenges to
enrollment centered around the need for high-touch engagement methods, time investment necessary for stakeholder inclusion, and the use of purely digital enrollment methods especially in populations under-represented in biomedical research.
These challenges occurred at the level of the individual, provider, institutions, and community, and cumulatively impacted
participant enrollment. Successful strategies for engagement and enrollment leveraged provider partners as advocates for
the program. For high-volume enrollment in clinical research, it is important to engage leaders in the healthcare setting,
patient providers, and tailor engagement and enrollment to potential participant needs. We emphasize the need for precision
engagement and enrollment methods tailored to individual needs.
Study Highlights
WHAT IS THE CURRENT KNOWLEDGE ON THE
TOPIC?
✔ Many clinical trials and research cohorts fail to achieve
enrollment targets and in large disease agnostic studies
enrolling diverse populations, there is limited evidence on
which enrollment strategies are successful.
WHAT QUESTION DID THIS STUDY ADDRESS?
✔ This review addressed how high-volume enrollment can be achieved in clinical research cohorts especially individuals under-represented in biomedical
research.

Cohort studies and clinical trials face the challenge of
meeting enrollment targets within stipulated timeframes
especially if the priority is to enroll individuals in groups
1

WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
✔ Our findings add to the body of empirical evidence on
successful strategies for enrollment in clinical research
stressing the importance of engagement of healthcare
leadership, providers, and study participants.
HOW MIGHT THIS CHANGE DRUG DISCOVERY,
DEVELOPMENT, AND/OR THERAPEUTICS?
✔ This study provides the opportunity to replicate successful strategies in high-volume enrollment. In enrolling a diverse
population in precision medicine, it is important to tailor engagement and enrollment strategies to individual needs.

under-represented in biomedical research.1,2 This challenge is compounded in disease-agnostic studies with
large sample sizes.3–5 The All of Us Research Program

Renal Section, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA; 2Division of Public Health Practice and Translational
Research, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA; 3Department of Internal Medicine, Kansas University Medical
Center, Kansas City, Kansas, USA; 4Department of Psychiatry, College of Medicine, University of Arizona, Tucson, Arizona, USA; 5College of Nursing, University of South
Florida, Tampa, Florida, USA; 6Department of Health Promotion Sciences, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona,
USA; 7University of Arizona Health Sciences, Tucson, Arizona, USA; 8Department of Medicine, College of Medicine Tucson, University of Arizona, Tucson, Arizona, USA;
9
Department of Medicine, College of Medicine Phoenix, University of Arizona, Tucson, Arizona, USA; 10Division of Community, Environment, and Policy of the UA Mel and
Enid Zuckerman College of Public Health, University of Arizona, Tucson, Arizona, USA; 11Department of Pharmacy Practice and Science, College of Pharmacy, University
of Arizona, Tucson, Arizona, USA; 12Banner Alzheimer’s Institute, Phoenix, Arizona, USA; 13Kansas University Medical Center, Kansas City, Kansas, USA; 14Department
of Pediatrics, University of Arizona, Tucson, Arizona, USA; 15Banner University Medical Group, Tucson, Arizona, USA; 16Division of Pulmonary, Critical Care and Sleep
Medicine, Department of Internal Medicine, Kansas University Medical Center, Kansas City, Kansas, USA. *Correspondence: Titilayo O. Ilori (tilori1@bu.edu)
Received: October 2, 2019; accepted: January 20, 2020. doi:10.1111/cts.12759

High-Volume Enrollment in Clinical Research
Ilori et al.
686

(AoURP) is a national cohort program that plans to enroll
one million or more core participants to serve as the research platform for precision medicine studies.6 The core
participants are individuals who enroll into the baseline cohort, undergo physical measurements, provide urine and
blood specimens, complete several questionnaire modules
(participant provided information), and agree to be followed
longitudinally.6,7 The goal is for about 50% of the national
cohort of AoURP core participants to be individuals
under-represented in biomedical research.8
The University of Arizona-Banner Health Provider
Organization (UA-Banner HPO) is one of the regional academic medical centers charged with enrolling 100,000
individuals into the AoURP. Of these 100,000 participants,
the UA-Banner HPO plans to enroll at least 50% of participants from Hispanic/Latino origin and 10% from other
race/ethnicities. Of the 6.07 million Arizonans in our AoURP
catchment area, ~ 60% (3.64 million) receive their health
care from Banner Health. All Banner Health facilities utilize
Cerner for their electronic health records. In addition to the
metropolitan areas, our health provider organization serves
patients from geographically remote populations in the
Sonoran Desert, border towns, and farming communities.
There is little data available on recruitment and retention
strategies into large population cohorts that are diseaseagnostic and hypothesis-free.9 This is especially challenging
when long-term recruitment and engagement of participants
(healthy or diseased) are needed and when there are no evident or immediate benefits or interventions being proposed
at the time of enrollment. We present the strategies, methods,
and challenges involved in the recruitment of over 30,000
participants into the UA-Banner AoURP over the first 2 years.

improving processes, providing additional training, and consolidating our operations.6 Figure 3 shows our targeted vs.
actual enrollment over the first 18 months.

METHODS

Establishment and implementation of an enrollment
center. Prior to starting an enrollment site, the AoURP
program leadership engaged both academic and hospital
leadership in the University. We partnered with the health
establishment, ensuring that we clearly defined shared goals,
expectations, and responsibilities of each entity, and how to
return value to involved parties. Following this, we arranged
meetings with key stakeholders (academic faculty, physicians,
nurses, and healthcare staff) from units in the healthcare
facility. Once the IRB and National Institute of Health (NIH)
approved potential enrollment sites, we identified suitable
working spaces, allowable signage (location, size, and other
details), and created opportunities for familiarization of the
healthcare teams with AoURP research staff.

Overview of the AoURP
To become a core participant in the AoURP, an individual first needs to consent to the research program and
then sign a separate consent to share electronic health
records. Subsequently, individuals’ complete electronic
surveys (basic demographic data, lifestyle, and health),
physical measurement assessment, and donation of biospecimens (urine, blood, and/or saliva).7 On average, a full
enrollment lasts 90–120 minutes. Enrollment can be done
entirely on-site or in a combination of on-line, pre-visit, and
on-site assessment of physical measurements and collection of biospecimens. Figure 1 illustrates the pathway to
becoming a core participant through the UA-Banner HPO.
Figure 2 shows the steps involved in the enrollment process for the AoURP. We obtained institutional review board
(IRB) approval from the central IRB of the AoURP.
We commenced by enrolling healthy volunteers during an
initial alpha phase between June 20, and July 5, 2017. In the
alpha phase, we enrolled a maximum of six participants per
day. This phase was a period focused on testing and refining protocols and systems from the biorepository at Mayo
Clinic in Rochester, Minnesota, and Data and Research
Center at Vanderbilt University in Nashville, Tennessee. The
subsequent beta phase of enrollment allowed for further
program expansion into the healthcare arena by testing and
Clinical and Translational Science

Building and maintaining infrastructure needed for
high-volume enrollment
The ideal populations for engagement and enrollment for
the UA-Banner HPO were adult patients (18 years and
older) from Banner Health facilities. Banner Health is one
of the largest nonprofit health systems in the United States
with > 400,000 patients (located across 29 sites in Arizona,
Colorado, Nebraska, Nevada, Wyoming, and California).
Geographic distribution of enrollment sites. Our
strategy was to focus on hospitals in the Banner Health
system located within central and southern Arizona, with
the desired demographics of individuals under-represented
in biomedical research. Our initial enrollment centers (n = 3)
had the following characteristics: (i) academic centers
with commitment to research; (ii) access to inpatient
and outpatient populations; (iii) resources of space and
equipment; and (iv) the presence of provider champions
and partners on site. Provider champions are high profile
medical leaders who are visible in the healthcare arena and
promote the AoURP in their healthcare facility. Provider
partners work in a dyad with the coordinator team and are
involved in the day-to-day enrollment of participants.
The UA-Banner HPO currently comprises 14 enrollment
sites serving the populations of Arizona and Colorado.
Enrollment sites are located within Banner medical centers
(n = 10), University of Arizona facilities (n = 3), and an approved
Federally Qualified Health Center in Nogales, Arizona (n = 1).

Establishment of enrollment units within clinical
centers. The characteristics that made a location ideal
for participant enrollment included: (i) a safe space for
participants and staff; (ii) proximity to where the individual
receives health care; (iii) high patient flow and regular influx
of new patients; and (iv) ability to establish partnerships
with healthcare team. Enrollment spaces were temporary
or permanent depending on the availability for use for the
AoURP teams. Our location and spaces were designed
with the convenience of the participant in mind. The use
of mobile enrollment carts (self-contained roll-along
luggage with all items needed for biospecimen collection
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Figure 1 Schematic showing the approaches to participants in the University of Arizona-Banner Health All of Us Research Program.

and physical measurement assessment) containing
necessary supplies, facilitated enrollment of participants
in this setting. Enrollment units had to be located close
to a laboratory processing space to allow for timely
delivery of biospecimens according to the processing
time requirements in the AoURP protocol (minimum of
30 minutes and a maximum of 4 hours).
Communication tactics for large research teams. There
were > 90 clinical research staff working for the UA-Banner
HPO across the 14 enrollment sites. GroupMe, Slack, and
WhatsApp texting were part of the initial communication
channels tested. Research teams later transitioned to
using Microsoft Teams for internal communications.
These instant communication channels allowed for timely
change in strategy (i.e., movement of additional staff to
high volume enrollment areas within hospitals and clinics),
to communicate needs for assistance with enrollments, and
also provide a means for broad dissemination of key program
information or changes for immediate implementation.
For overall oversight for the UA-Banner HPO communications, we hired a local communications manager as the

liaison to the national AoURP communications team and
was responsible for all external and internal communications and adequate signage at the clinical sites.
Staffing models. To estimate the number of staff
needed to accomplish a daily enrollment of about 100
core participants, we considered the following factors:
(i) conversion rate (proportion of individuals enrolled
into cohort as a percentage of those approached); (ii)
time to enroll participant (90–180 minutes depending on
participant needs and language, with an allowance of
additional time to enroll Spanish speakers and persons
with low digital literacy; (iii) number of work days/
year (≈ 247 days); and (iv) low enrollment secondary to
inclement weather days (summer months in Arizona
plagued with excessive high temperatures, monsoon
rains, and dust/ozone warnings, which will limit outings of
the team members).
Staff training. We developed a structured program for
training of newly hired individuals under the oversight of
a specialized training team. This team, comprised of a
www.cts-journal.com
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Figure 2 Per quarter actual vs. target enrollments in the All of Us Research Program, University of Arizona-Banner Heath, Health
Provider Organization (June 2017–December 2018).

Figure 3 Enrollment process in the University of Arizona-Banner Health All of Us research Program.

clinical research manager and senior clinical research
coordinators, was primarily responsible for the training and
on-boarding of the over 90 clinical research coordinators,
20 engagement coordinators, and support staff. We
developed and used training modules consisting of general
onboarding information, human subjects’ protection,
research compliance certification, AoURP protocol, data
entry at the health provider organization level for scheduling
and management (Research Electronic and Data Capture
(REDCap)), other data platforms for data collection by
AoURP and cultural competency. Emphasis on rapport
building and training about eye contact, body posture,
and vocal cadence were keys to success for the program
staff and equipped them to be the “face of the research
program.” The training program also ensured program staff
Clinical and Translational Science

had the tools to engage, educate, and enroll participants at
all levels, while ensuring a first-rate participant experience
to establish a long-term partnership with the AoURP.
We ensured that our workforce was culturally and linguistically congruent with the population of Arizona. Of our > 90
research staff, 45% were bilingual in English and Spanish.
Our engagement team comprised of 20 engagement coordinators and Spanish promotores who are trusted members
of the Hispanic/Latino community with specialized training to
provide education/information on precision health to members of their communities and create awareness about the
AoURP.10 About 88% of the engagement coordinators were
bilingual in English and Spanish and of Hispanic/Latino origin. All team members underwent rigorous cultural sensitivity
training.
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Enrollment strategies
Physician champions and physician partners. Providerpatient relationship built on trust is a key predictor of health
outcomes as well as a predictor for successful recruitment of
patients as research participants.11 Provider-patient rapport
is an asset for engagement and enrollment of research
participants in the healthcare setting. By identifying provider
champions, we were able to disseminate information about
the program to other providers and staff in the hospitals
and clinics. Provider champions formed a conduit for other
physicians or providers who were interested in participating
in the program. They also provided opportunity for the
active engagement of provider partners. Provider partners
are classified as active partners (discuss AoURP with their
patients) or passive partners (simply provide the AoURP team
access to their patient population). We educated provider
partners to familiarize them with the AoURP and provide
them with answers to commonly asked questions about the
program.
Our approach to provider engagement in this research
program was to emphasize the benefits of participation in the
AoURP for patients and future participants: (i) increased patient satisfaction by being invited to participate in research;
(ii) future return of value (for example, pharmacogenomic
results) to core participants in the AoURP; (iii) coordinating participant enrollment visits before or after clinic visits
thereby decreasing “no-show” rates and reducing transportation burden to participants; (iv) enabling providers to
identify future research opportunities; (v) ongoing access to
multimedia educational materials and continuing medical
education opportunities12 (for example Test2Learn to enrich
provider knowledge about pharmacogenomics); and (vi) updates on metrics and milestones of the AoURP.

staff in the inpatient setting. Therefore, we established
partnerships with physician leadership in the hospitalist
groups. Our initial workflows had provider partners
approaching patients on the inpatient service and informing
them of the goals and objectives of the AoURP. However,
this approach proved too cumbersome and impractical for
busy clinicians. The current workflow, now utilized across
our inpatient enrollment sites, uses the physicians as
passive partners (allowing access to patients) and nurses
as active partners. Nurses guide the AoURP research team
on which patients are appropriate to approach based on
the protocol and current medical status and informing the
research team of an ideal time to approach based on the
level of acuity of the patient, reason for admission, and
the schedule for the patient. Only when the patient’s nurse
confirms that the patient can be approached to discuss
participation in the AoURP, does the clinical research
coordinator approach the patient, introduce self, job title,
and ask for permission to discuss the AoURP. If the patient
refuses to participate, the decision is noted in REDCap and
Cerner (Figure 1). If the patient decides to enroll, the entire
enrollment process can be conducted in the patient’s room
using iPads and mobile enrollment carts.
Patients may also opt to defer their enrollment visit
until after hospital discharge. In that case, our team would
contact the patient 2 weeks after discharge to discuss
participation and to schedule an enrollment visit that ideally coincides with a subsequent healthcare visit to reduce
the transportation burden on the participant. Using our
electronic medical records, we are able to indicate which
individuals were approached and the outcome of the approach which could be: (i) enrollment; (ii) decline; or (iii)
needing further conversation.

Outpatient enrollment: Physician-coordinator dyad.
Potential provider champions may be academic faculty
with a relatively small clinical footprint or providers with a
large clinical practice. AoURP medical directors would
initiate discussions with providers and foster relationships
between provider partners and the AoURP research team.
The methods of navigating engagement and enrollment in
the outpatient setting could follow any of several paths: (i)
provider gives brief presentation of the AoURP to patient
with hand-off to the research team (this demonstrates the
highest conversion rate); (ii) provider asks patient if AoURP
research staff could speak with them; or (iii) clinical research
coordinators may send IRB-approved invitation letters
from the AoURP, signed by the provider, to patients prior to
appointment time (Figure 1). Research staff made follow-up
calls to patients who received the signed AoURP letters and
answered additional questions about the program. Research
staff recorded a refusal to participate in the research program
REDCap and Cerner, to prevent re-contact of those persons
who declined participation. Interested participants were
ideally scheduled on the same day or close to their future
appointment with the provider as per their convenience.

Information tables: A participant walk-in and realtime scheduling strategy. Tabling involves a table
emblazoned with AoURP signage, strategically situated
in high traffic areas within the healthcare facility (hospital
or clinic lobby). The audience for this activity could
include patients; patient’s family members/friends;
general passers-by; facility staff; and providers. Possible
outcomes from tabling activity include: (i) real-time
enrollment of the participant for a walk-in visit (a backup
AoURP staff member is contacted to accompany the
potential participant to the on-site enrollment unit); (ii)
engagement and scheduling of an enrollment visit for a
future date; (iii) completion of an interest card so contact
can be made with the individual at a later date to provide
more information; or (iv) lack of interest in participation
(see Figure 1).

Inpatient enrollment: Nurses and doctors as provider
champions. Early in our program, we recognized the
importance of partnering with physicians and nursing

Community engagement activities. We identified
activities, such as community fairs, health fairs, healthrelated professional societies and advocacy associations,
lectures, and community events (suggested by our
participant engagement board) and obtained permission
for the AoURP information tables and program literature to
be shared at such events. The engagement team generated
multiple opportunities for engagement within groups of
individuals under-represented in biomedical research
www.cts-journal.com
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and established community partners, such as community
service agencies, churches, community centers, schools,
and family resource centers. With a limited budget for
purchased media, our health provider organization took
advantage of earned media, press releases, public service
announcements, TV, radio interviews, and social media to
publicize AoURP.
Since the protocol development and initial launch, no
recruitment efforts have focused on American Indian or
Alaska Native individuals or tribes. Nationally, the leadership of the AoURP and American Indian or Alaska Native
tribes are engaged in bidirectional and culturally sensitive
discussions to develop collaborations between the AoURP
and American Indian or Alaska Native. The UA-Banner
HPO held a 2-day conference in 2017 with the tribal leadership titled, “Regional American Indian/Alaska Native Tribal
Dialogue Conference on the All of Us Research Program on
Precision Medicine,” the first of its kind in the AoURP. We
continue to support efforts of the AoURP at the national
level in the discussions and collaborations with the tribal
leadership. Locally, we have an American Indian or Alaska
Native working group assisting in our supportive efforts to
build awareness. A unique barrier to enrollment and engagement is mistrust because of historical transgressions.
It is important to note that issues related to (i) tribal sovereignty and consent, (ii) governance, (iii) culturally sensitive
engagement, and (iv) ethics and IRB oversight specifically
pertaining to biospecimen storage and access need to
be addressed in the discussions with American Indian or
Alaska Native sovereign nations. Having American Indian
or Alaska Native representation in the governance of the
AoURP at national and health provider organization levels
is one crucial step for future meaningful collaborations between AoURP and tribal nations.
Presentations. To introduce the AoURP in our immediate
community, we presented to various groups within the
healthcare facilities. The audience included leaders and
stakeholders within the institutions ranging from senior
hospital administration to physicians and nurses as well as
community leaders (e.g., Hispanic Chambers of Commerce).
One outcome of these educational opportunities was the
ability to engage and enroll interested members of the
healthcare team, allowing for firsthand experience with the
program. These individuals often went on to be unofficial
ambassadors for the AoURP.
Digital and print enrollment strategies. We used a series
of digital enrollment strategies targeted at individuals
who could utilize a digital platform for engagement and
enrollment. Prior to the start of the program, we designed a
pre-interest website for persons interested in the program
to provide contact information that would be used at a
later date. Other digital strategies include the AllofUsAZ.
org website and a URL unique to the UA-Banner HPO. We
utilized IRB-approved emails to Banner Health facility staff
informing of the local launch of the AoURP and provided
contact information so that interested individuals could
learn more about the program. These emails stressed the
voluntary nature of the research program and contained
Clinical and Translational Science

language and disclaimers to avoid the potential for
coercion.
DISCUSSION
In the new era of large prospective cohorts, it has been suggested that process expertise is as important as scientific
rigor; therefore, developing and testing cost-efficient and
effective methods of high-volume enrollment and retention
becomes vital.13 Globally, there are more emerging cohorts
with large recruitment and enrollment targets for example
the United Kingdom Biobank has already enrolled 500,000
individuals.13,14 The added challenge of enrolling individuals from under-represented groups in biomedical research
makes it crucial to ensure tested, cost-effective strategies
are identified, such as those we report in this paper.
Pure digital enrollment strategies were not as effective as in-person enrollment strategies.15 We found the
highest enrollments among our population from in-person
approaches on the inpatient service, outpatient clinics, and
AoURP staffed information tables as opposed to pure digital approaches. Although access to digital technology is
increasing among various age groups, there is decreased
access to the internet and information technology among
racial and ethnic minorities, persons with disabilities, rural
populations, and individuals with various levels of socio-economic status. This is known as the “digital divide”
evidenced by data that blacks and Hispanics are less likely
than the national average to own a computer, have internet
access, and have access to the internet at home.16,17
As part of our strategies to reduce the digital divide, our
enrollment sites became “hubs” for guiding and assisting participants with digital technology, such as navigating
the use of iPads. Research coordinators provided support
to participants for registering and creating accounts in the
AoURP. We made adjustments in our workflow to accommodate the additional time needed for individuals who were
not accustomed to using digital devices. At the national
level, the use of phone numbers in the registration process
as opposed to only emails also helped in the registration
process for individuals who were not accustomed to email
use. Where needed, and based on participant preference,
we used desktop computers for older participants because
it was easier for them to navigate. Digital literacy continues
to be an ongoing challenge that needs further attention and
research in individuals who are under-represented in biomedical research.
The barriers to enrollment we encountered include reluctance of participants to enroll due to concerns about data
security and privacy, questions surrounding the potential
impact on employment and health insurance, and general
lack of knowledge of precision medicine (Table 1). Previous
studies have shown that there is a high level of suspicion and
mistrust among minority populations participating in medical
research.18,19 We used strategies such as educating participants on precision medicine, hiring and training a diverse
workforce to whom participants were able to relate, meaningful community engagement, and educating participants on
our certificate of confidentiality to mitigate mistrust and build
participants’ confidence in the program (Table 1). Our team
members exemplified qualities, such as flexibility, adaptability,
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Table 1 Barriers, challenges, and solutions to high-volume enrollment in clinical research studies
Barrier/challenge to high volume enrollment
High touch methods needed for general population, especially
under-represented minorities in medical research

Solutions to the challenges
Use high-touch strategies for engagement and enrollment, invest
in staffing, and training

Building infrastructure

Invest the funds and time in building infrastructure, use best
practices

Physician engagement

Invest time, resources, and personnel in physician engagement

Leadership and stakeholder engagement
Staff retention and satisfaction
Digital enrollment
Data and security concerns of participant

Invest time, resources, and personnel
Training, career development trajectories, culture, and values
Training participants, invest time
Train staff on talking points around data security
Emphasize data security measures

Mistrust of clinical research
Time for enrollment and avoiding interruption of the clinical workflow

compassion, rapport-building, and cultural competence, necessary for participant engagement and enrollment.20
Horowitz et al. reported findings similar to our experience,
that community involvement by project staff may be more
crucial in the retention of African Americans and Latinos than
the initial recruitment.21 Other barriers to enrollment identified
by previous studies include the provider referral in introducing and explaining clinical trials, group-specific barriers, which
may be present in various cultural and heath beliefs within
various racial or ethnic groups, socioeconomic status, and
institutional factors, such as organizational buy-in, size, and
staffing.22–28
We experienced similar findings to Joseph et al.29 who
show that there are institutional barriers to recruiting minorities to cancer clinical trials. These barriers include a lack of
engagement by the providers or hospital leadership, the organizational climate of a healthcare institution, including clinic
space, structure, hours, methods of patient assignment, and
research-specific resources, such as staff, funds, and availability of appropriate linguistic and literacy resources.29
Damashek et al. in their study highlighted the importance
of flexibility and the ability to tailor programs to participant
needs in engagement and retention.30 Part of an individualized experience is making enrollments as convenient as
possible for participants enrolling in different arenas within
the healthcare setting. The ability to enroll within the clinic
helps to reduce the burden of the research visit on the participant and linking appointments to clinic or other healthcare
visits helps to reduce the burden of multiple visits.
A complex interplay of individual, provider, program, and
community factors synergistically affect participant enrollment, engagement, and retention.30 Failure at any of these
levels could result in failure of meeting enrollment targets.
Precision medicine is geared at tailoring medical treatment
to the needs of the individual; in practicing precision enrollment, it is important to tailor strategies to the individual
subpopulations and geographic areas.
A review of 114 clinical trials in the United Kingdom
shows that less than a third of the trials (31%) met
recruitment targets.4 This is also problematic in longitudinal cohorts, as exemplified in the National
Children’s Study.31 Part of the lessons learned from cohorts, like the National Children’s Study, is that it is

Piloting various iterations of the research workflow to ensure
minimal interruption to the clinic workflow

necessary to clearly define recruitment strategies a priori especially within specialized populations. However,
there are very few randomized control trials testing
recruitment strategies and fewer in individuals underrepresented in biomedical research. Our findings add
to the body of empirical evidence and will provide the
opportunity to replicate successful strategies in future
high-volume enrollment studies. To our knowledge, the
AoURP is the first time in the United States that such a
high-volume of research participants would be enrolled on
a daily basis.
Our research program was able to exceed enrollment
goals in the first 2 years because of the successful engagement of the highest level of leadership of the University of
Arizona and Banner Health, engagement of local leaders at
the different Banner Health facilities, and the engagement of
our healthcare team partners. Additionally, we respectfully
leveraged the physician-patient relationship to create an atmosphere of rapport and trust for the UA-Banner AoURP
team in the clinical arena, and by building a team of clinical
research and engagement staff who are committed to the
vision of the research program.
Aside from the large number of participants, there are
other unique characteristics that differentiate the AoURP
from other longitudinal cohort studies. Participants agree
to (i) ongoing accessibility to health records by participating and sharing electronic health records on a continuous
basis, (ii) providing biospecimens for laboratory and genetic
testing (DNA samples), and (iii) use of mobile health technology to gather geospatial and environmental data.6,32
Most longitudinal cohorts are considerably smaller, lack
diversity, and do not possess comprehensive phenotypic
and genetic data.6 The AoURP is disease agnostic and is
currently enrolling all disease types and all health status.
Although we anticipate the return of genetic and other laboratory results in a portion of participants in the future, at
the current time, there is no immediate short-term benefit
to participants. The perceived lack of a short-term benefit
(aside from immediate return of physical measurements at
the time of enrollment), poses a unique challenge in enrolling potential participants. Coupled with the additional
challenge of participants consenting to sharing their electronic medical records on a continuous basis, with no
www.cts-journal.com
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specific end-date, research coordinators have to provide
potential participants with additional explanations and education on why it is important to participate.
Faced with these peculiar characteristics of our research
program, we tested known strategies of enrollment in clinical
research. The leading approaches that successfully enrolled
individuals traditionally under-represented in biomedical research were strategies involving the use of information tables,
physician-coordinator dyads, and engaging provider champions on the inpatient and outpatient settings. Considering
participants’ preferences on where and how enrollment occurred was also an important feature of our enrollment process.
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